跳至主要内容
临床试验/NCT01310686
NCT01310686Unknown不适用

Genotypic Evaluation of Chronic Exudative Macular Degeneration Despite Monthly Anti-Vascular Endothelial Growth Factor (VEGF) Therapy

West Coast Retina Medical Group, Inc.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Genetic analysis of patients with chronic wet age-related macular degeneration despite continuous anti-VEGF treatment

研究概览

简要总结

To obtain a genotypic analysis of patients with chronic exudative age-related macular degeneration noted to have subretinal or intraretinal edema despite continuous monthly Anti-VEGF therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Ability to provide written informed consent for participation in this study
  • Subjects diagnoses of neovascular AMD who are on a monthly anti-VEGF regimen (have had >10 or more ranibizumab and/or bevacizumab injections within the last year) and who still have intra-retinal or subretinal fluid as confirmed by the Investigator

排除标准

  • Subjects with a Pigment Epithelial Detachment Exclusively
  • Subjects with Serous Pigment Epithelial Detachments
  • Subjects with history of the following:
  • idiopathic polypoidal choroidal vasculopathy
  • pathologic degenerative myopia
  • central serous chorioretinopathy
  • familial drusen
  • adult onset foveal pattern dystrophy

结局指标

主要结局

Genetic analysis of patients with chronic wet age-related macular degeneration despite continuous anti-VEGF treatment

时间窗: This is a one time only blood draw.

次要结局

  • To evaluate demographic and clinical characteristics in patients treated with anti-VEGF therapy who fail to respond completely.(This is a one time only blood draw and assessment of clinical characteristics.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Arthur D. Fu, MD

Principal Investigator

West Coast Retina Medical Group, Inc.

研究点 (1)

Loading locations...

相似试验